Our findings align with the known functions of IL-6, IL-17, and TNF-α inhibitors, indicating that XYAS, LXJD, and QXAS could significantly reduce IL-6, IL-17, and TNF-α levels and exert an inhibitory effect on epidermal thickening in mice with psoriasis and SDs. Here, IL6 is linked to psoriasis.